Q3313607 (Q3313607): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed an Item: Edited by the infer coords bot - inferring coordinates from location) |
||||||||||
Property / coordinate location | |||||||||||
51°20'26.27"N, 12°22'29.03"E
| |||||||||||
Property / coordinate location: 51°20'26.27"N, 12°22'29.03"E / rank | |||||||||||
Normal rank |
Revision as of 20:17, 24 October 2021
Project Q3313607 in Germany
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q3313607 in Germany |
Statements
347,150.02 Euro
0 references
433,937.52 Euro
0 references
80.0 percent
0 references
11 January 2018
0 references
30 April 2021
0 references
Adversis Pharma GmbH
0 references
Entwicklung eines diagnostischen Tests (ELISA) zum Nachweis von Antikörpern gegen das Tumorantigen NY-ESO-1 (German)
0 references
Leipzig, Stadt
0 references
Identifiers
672 / 101003528841
0 references